Granules India informs about press release

22 Dec 2025 Evaluate
Granules India has informed that it enclosed the press release given by the Company titled ‘Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

600.90 17.60 (3.02%)
22-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.25
Dr. Reddys Lab 1283.85
Cipla 1512.50
Zydus Lifesciences 918.20
Lupin 2126.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×